We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$12.2B
AUM Growth
+$1.03B
Cap. Flow
+$49.2M
Cap. Flow %
0.4%
Top 10 Hldgs %
25.44%
Holding
2,628
New
63
Increased
565
Reduced
814
Closed
130

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$379M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$14.1M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$12.6M
4
EPAM icon
EPAM Systems
EPAM
+$8.07M
5
AA icon
Alcoa
AA
+$4.54M

Top Sells

Rank Stock Value
1
EPD icon
Enterprise Products Partners
EPD
+$31.9M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$31.2M
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$28.5M
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$20.9M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 12.24%
3 Financials 12%
4 Consumer Discretionary 11.44%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FUTU icon
2226
Futu Holdings
FUTU
$14.7B
$152K ﹤0.01%
3,500
– –
ATOM icon
2227
Atomera
ATOM
$216M
$151K ﹤0.01%
7,526
– –
CGEM icon
2228
Cullinan Oncology
CGEM
$1.26B
$151K ﹤0.01%
9,808
– –
AFMD
2229
DELISTED
Affimed
AFMD
$151K ﹤0.01%
2,739
-1,424
-34% -$88K
CMRE icon
2230
Costamare
CMRE
$1.71B
$151K ﹤0.01%
11,946
-6,591
-36% -$86.2K
DCO icon
2231
Ducommun
DCO
$3.04B
$151K ﹤0.01%
3,227
-1,765
-35% -$84.3K
ALNT icon
2232
Allient
ALNT
$1.94B
$151K ﹤0.01%
4,130
+1,601
+63% +$59.2K
EBTC
2233
DELISTED
Enterprise Bancorp
EBTC
$151K ﹤0.01%
3,354
– –
OPRT icon
2234
Oportun Financial
OPRT
$346M
$150K ﹤0.01%
7,407
– –
CTT
2235
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$150K ﹤0.01%
17,205
+5,861
+52% +$52.2K
DYN icon
2236
Dyne Therapeutics
DYN
$4.89B
$150K ﹤0.01%
12,586
– –
APYX icon
2237
Apyx Medical
APYX
$126M
$150K ﹤0.01%
11,665
– –
SMBK icon
2238
SmartFinancial
SMBK
$898M
$149K ﹤0.01%
5,462
– –
STER
2239
DELISTED
Sterling Check Corp. Common Stock
STER
$149K ﹤0.01%
+7,285
New +$172K
TRML
2240
DELISTED
Tourmaline Bio
TRML
$149K ﹤0.01%
+976
New +$144K
ALBO
2241
DELISTED
Albireo Pharma Inc
ALBO
$149K ﹤0.01%
6,398
– –
BLFS icon
2242
BioLife Solutions
BLFS
$1.71B
$149K ﹤0.01%
3,986
-5,112
-56% -$219K
VLDR
2243
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$149K ﹤0.01%
32,008
+15,913
+99% +$93K
BGFV
2244
DELISTED
Big 5 Sporting Goods
BGFV
$149K ﹤0.01%
7,812
– –
DCPH
2245
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$148K ﹤0.01%
15,140
– –
MRNS
2246
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$148K ﹤0.01%
12,435
– –
TBCH
2247
Turtle Beach Corp
TBCH
$230M
$148K ﹤0.01%
6,636
– –
SPNE
2248
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$148K ﹤0.01%
10,839
– –
IMA
2249
ImageneBio Inc
IMA
$68M
$147K ﹤0.01%
+979
New +$159K
MCS icon
2250
Marcus Corp
MCS
$914M
$147K ﹤0.01%
8,228
+4,070
+98% +$76.2K
88 89
90
91 92

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, MetLife Investment Management held 2,628 positions worth $12.2B, up 9.2% from $11.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2021 filing shows 63 new, 565 increased, 814 reduced and 130 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M. The largest sale was Enterprise Products Partners, an estimated $31.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M.
  • MetLife Investment Management added most to iShares Russell 2000 ETF in Q4 2021, an estimated $14.1M increase.
  • MetLife Investment Management's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $31.2M.
  • MetLife Investment Management fully exited Enterprise Products Partners in Q4 2021, selling an estimated $31.9M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.2B portfolio in Q4 2021.
  • MetLife Investment Management opened 63 new positions and closed 130 in Q4 2021.
  • MetLife Investment Management's portfolio value rose 9.2% quarter-over-quarter to $12.2B.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.